Low serum complement C3 levels are associated with adverse c…
Emerging
0
Citations37
Refs2025
Year
Search Works
Work Details
- DOI 10.1016/j.leukres.2025.108116
- PMID https://pubmed.ncbi.nlm.nih.gov/41075453
- OpenAlex ID W4414798840
- Type Article
- Language EN
- Published 03 Oct 2025
- Volume 158
- Pages 108116
- Source Leukemia Research
- Publisher Elsevier BV
- Countries 1
- Institutions 3
- Added 10 Oct 2025
- Updated 08 Oct 2026
External Links
MENU
0
Low serum complement C3 levels are associated with adverse clinical outcomes in myelodysplastic syndromes
Article 2025 EN Hybrid
BACKGROUND: Complement C3, a critical component of the complement system, has been implicated in cancer risk across various malignancies. However, its role in myelodysplastic syndromes (MDS) remains inadequately explored. This study investigates the impact of serum complement C3 levels on survival outcomes in patients with MDS. METHODS: Clinical data, including demographic characteristics (sex and…
0
Citations
37
References
7
Authors
0.00
FWCI
Topics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
7 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Duobing Zou | Ningbo University (CN) | |
| 2 | Huanhuan Ying | Ningbo University (CN) | — |
| 3 | Yong Liang | Ningbo University (CN) | |
| 4 | Jie Cao | Ningbo University (CN) | — |
| 5 | Yanqing Liu | Ningbo University (CN) | |
| 6 | Guifang Ouyang | Ningbo University (CN) Ningbo University Affiliated H… (CN) +1 | |
| 7 | Qitian Mu | Ningbo University (CN) | — |
Data: OpenAlex